Basics of Clinical Trials
-
Speaker : KETAN DESAI
-
When : Friday, May 30, 2025
-
Time : 01 : 00 PM EST
-
Add To Calendar
Refer a Friend
Ketan Desai, MD PhD, is an immunologist. He has more than 13 patents, and has developed 5 drugs that are on the market for rheumatology and oncology indications. He is the founder and CEO of IMC Radiology, the founder and CEO of Immacule Cosmetics, founder and Chief Medical Officer of Levolta Pharmaceuticals and founder of Nutent Therapeutics. The last company's product is based on curcumin and is sold in US as Volt03.
Useful for those entering the pharma industry or academics to understand how clinical trials are conducted. The study objectives, endpoints, entry criteria, study visits, evaluations, safety assessments, statistical considerations, manufacturing and compound supply, and regulatory considerations. The design of randomized, placebo studies can be open label or blinded (single, double, or triple-blinded). Single site versus multiple sites, advantages and disadvantages. Considerations of gender, age, and race are to be taken into account. Issues facing trials in other countries.
Areas Covered
- Study objectives
- Eendpoints
- Inclusion and exclusion criteria
- Study visits
- Study evaluations
- Safety assessments
- Statistical considerations
- Manufacturing and compound supply
- Regulatory considerations
Who Should Attend
Beginners in the pharma industry and academia
Why Should You Attend
Useful for those entering the pharma industry or academics to understand how clinical trials are conducted. The study objectives, endpoints, entry criteria, study visits, evaluations, safety assessments, statistical considerations, manufacturing and compound supply, and regulatory feedback
Topic Background
How are clinical trials designed and conducted?
-
$160.00
-
